Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $7.33 which represents a decrease of $-0.20 or -2.66% from the prior close of $7.53. The stock opened at $7.64 and touched a ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

We recently compiled a list of the These 10 Companies Led Gains on Wednesday. In this article, we are going to take a look at ...

Recursion Pharmaceuticals Inc (RXRX) stock saw a modest uptick, ending the day at $7.49 which represents a slight increase of $0.61 or 8.87% from the prior close of $6.88. The stock opened at $7.17 ...

Shares of Recursion Pharmaceuticals (RXRX) have gained 4% over the past four weeks to close the last trading session at $7.26, but there could still be a solid upside left in the stock if short-term ...

SALT LAKE CITY - Recursion Pharmaceuticals (NASDAQ: RXRX), a clinical stage company specializing in drug discovery with a market capitalization of $2.28 billion, has received ...

Leerink Partnrs cut their FY2024 earnings estimates for shares of Recursion Pharmaceuticals in a research note issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now expects that ...

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 26,172 calls trading, 4x expected, and implied vol increasing almost 7 ...

Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Recursion Pharmaceuticals (RXRX – Research Report) today and set ...

In this article, we are going to take a look at where Recursion Pharmaceuticals (NASDAQ:RXRX) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped ...